You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Casodex monotherapy

Showing 26 - 50 of 3,453
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +8 more
Jan 17, 2023

Advanced Solid Tumor Trial in Nanchang, Shanghai (QL1604)

Active, not recruiting
  • Advanced Solid Tumor
  • Nanchang, China
  • +1 more
Mar 24, 2023

KRAS P.G12C, Pancreatic Cancer Trial in Beijing (JAB-21822)

Not yet recruiting
  • KRAS P.G12C
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +1 more
Aug 18, 2023

TNFi as Monotherapy or Combination Therapy With MTX and Compare

Completed
  • Rheumatoid Arthritis
  • patterns of use of combination therapy and monotherapy
  • New York, New York
    Pfizer
Oct 7, 2022

Sciatica Acute, Sciatica Trial in Rawalpindi (Lacosamide 50 MG Oral Tablet [Vimpat], Codeine Phosphate, Diclofenac Sodium)

Completed
  • Sciatica Acute
  • Sciatica
  • Lacosamide 50 MG Oral Tablet [Vimpat]
  • +2 more
  • Rawalpindi, Punjab, Pakistan
    Mehreen Mirza
Nov 15, 2022

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)

Not yet recruiting
  • Coronary Artery Disease
  • Clopidogrel monotherapy
  • Tailored anti-platelet therapy
  • Seoul, Korea, Republic of
    Severance Hospital
Jul 3, 2023

Type 2 Diabetes Trial in China (Tirzepatide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Beijing, Beijing, China
  • +29 more
Jul 19, 2023

Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)

Recruiting
  • Essential Hypertension
  • D064 and D702, QD
  • +2 more
  • Seoul, Seongdong-gu, Korea, Republic of
    Hanyang University Seoul Hospital
Nov 7, 2023

Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)

Recruiting
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +35 more
Jan 12, 2023

Advanced Solid Tumors Trial in Guangdong (JS019)

Recruiting
  • Advanced Solid Tumors
  • JS019
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Aug 17, 2022

Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • +2 more
  • San Diego, California
  • +7 more
Jan 23, 2023

Advanced Solid Tumor Trial in Beijing (BB3008 tablet)

Recruiting
  • Advanced Solid Tumor
  • BB3008 tablet
  • Beijing, Beijing, China
  • +1 more
Nov 19, 2023

Prostatic Tumors Trial in Toronto (hypoxia measurement)

Active, not recruiting
  • Prostatic Neoplasms
  • hypoxia measurement
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 1, 2021

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Jun 1, 2023

Advanced Cutaneous Squamous Cell Carcinoma Trial in Worldwide (cemiplimab)

Active, not recruiting
  • Advanced Cutaneous Squamous Cell Carcinoma
  • Phoenix, Arizona
  • +77 more
Jan 4, 2023

HIV Trial in Worldwide (VH3739937, Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +18 more
Sep 22, 2023

Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

Not yet recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel plus Pembrolizumab
  • Pembrolizumab with Optional Crossover Period
  • (no location specified)
Feb 13, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Autoimmune Hypothyroidism Trial in Netherlands (LT3 (liothyronine), Placebo)

Recruiting
  • Autoimmune Hypothyroidism
  • LT3 (liothyronine)
  • Placebo
  • Amsterdam, Netherlands
  • +14 more
Jan 4, 2023

Advanced Solid Tumor Trial in San Antonio (LB101)

Recruiting
  • Advanced Solid Tumor
  • San Antonio, Texas
    NEXT Oncology
Apr 6, 2023

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,

Recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • Birmingham, Alabama
  • +14 more
Oct 11, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023